How to order Diprivan
Choose from these suppliers to see NDC numbers and other details for the sizes and strengths of Diprivan.
DIPRIVAN 100 mg per 10 mL
NDC No. 63323-
269-16
Vial Size
10 mL
Description
Single Patient Use Vial
Closure
20 mm
Concentration
10 mg per mL
Unit of Sale
10
Min Direct Order Qty
1 x 10
Cardinal
5691464
Cencora
10252578
McKesson
1594803
Morris & Dickson
N/A
DIPRIVAN 200 mg per 20 mL
NDC No. 63323-
269-37
Vial Size
20 mL
Description
Single Patient Use Vial
Closure
20 mm
Concentration
10 mg per mL
Unit of Sale
10
Min Direct Order Qty
1 x 10
Cardinal
4923025
Cencora
McKesson
Morris & Dickson
DIPRIVAN 500 mg per 50 mL
NDC No. 63323-
269-57
Vial Size
50 mL
Description
Single Patient Use Vial
Closure
32 mm
Concentration
10 mg per mL
Unit of Sale
20
Min Direct Order Qty
1 x 20
Cardinal
4925590
Cencora
McKesson
Morris & Dickson
DIPRIVAN 1,000 mg per 100 mL
NDC No. 63323-
269-67
Vial Size
100 mL
Description
Single Patient Use Vial
Closure
32 mm
Concentration
10 mg per mL
Unit of Sale
10
Min Direct Order Qty
1 x 10
Cardinal
Cencora
McKesson
Morris & Dickson
829911
NOVAPLUS® is a registered trademark of Vizient.
Each vial contains:
Propofol suitable for intravenous administration:
10 mg per mL
Soybean oil: 100 mg per mL
Glycerol: 22.5 mg per mL
Egg lecithin: 12 mg per mL
Disodium edetate: 0.005%
Sodium hydroxide: to adjust pH
Store between 4° to 25°C (40° to 77°F). Do not freeze. Shake well before use.
Customer Service
To order Diprivan
Diprivan should be ordered through your wholesaler. For more ordering information, please contact your account representative or our Customer Service Department, Monday through Friday, 7 am–6 pm (CST) at:
Medical Affairs
If you have a question regarding the safe and effective use of DIPRIVAN, please contact the Fresenius Kabi Medical Affairs Department Monday through Friday from 8 am–5 pm (CST) at:
Important Safety Information
CONTRAINDICATIONS
DIPRIVAN is contraindicated in patients with Known hypersensitivity to propofol, egg or soybean.
WARNING AND PRECAUTIONS
Hypersensitivity Reactions: Serious and sometimes fatal reactions.
Microbial Contamination: Strict aseptic technique must be maintained during handling. DIPRIVAN vials are never to be accessed more than once or used on more than one person. Administration should commence promptly and be completed within 12 hours after the vial has been opened. Discard unused drug product. Do not use if contamination is suspected.
Cardiovascular depression: Cases of bradycardia, asystole, and cardiac arrest have been reported. Pediatric patients are susceptible to this effect, particularly when fentanyl is given concomitantly.
Read More
ADVERSE REACTIONS
The most common adverse reactions >1% were bradycardia, arrhythmia, tachycardia, hypotension, hypertension, decreased cardiac output, movement, apnea, respiratory acidosis during weaning, rash, pruritus, burning/stinging or pain at injection site, and hyperlipemia.
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA at 1-800-551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
DRUG INTERACTIONS
Opioids, Sedatives or Other Analgesic Agents: May increase the anesthetic/ sedative and cardiorespiratory effects.
Valproate: May lead to increased blood levels of propofol.
INDICATIONS AND USAGE
DIPRIVAN is an intravenous general anesthetic and sedation drug indicated for:
- Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age.
- Maintenance of General Anesthesia for Patients Greater than or Equal to 2 Months of Age.
- Initiation and Maintenance of Monitored Anesthesia Care (MAC) Sedation in Adult Patients.
- Sedation for Adult Patients in Combination with Regional Anesthesia.
- Intensive Care Unit (ICU) Sedation of Intubated, Mechanically Ventilated Adult Patients.
Limitations of Use:
- DIPRIVAN is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months.
- MAC sedation in the pediatric population is not recommended. DIPRIVAN is not indicated for use in Pediatric ICU sedation.
This Important Safety Information does not include all the information needed to use DIPRIVAN® (Propofol), Injectable Emulsion, USP safely and effectively. Please see full prescribing information for DIPRIVAN® (Propofol), Injectable Emulsion, USP. Full prescribing information is also available at www.fresenius-kabi.com/us.